Clinical trial

Dapagliflozin in Type 1 Diabetes

NCT02211742

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-08-01

PhasePHASE4

Study timeline

Study start (actual)2014-08-01Date precision: month

Registry last updated2023-03-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Fasting Glucoseunresolved

Glucose Excursionunresolved

Glycemic Controlunresolved

Interventions

DapagliflozinDRUG · verified · RxNorm: dapagliflozin

Sponsors & collaborators

Medical University Innsbrucklead sponsor

Medical University of Grazcollaborator

University of Berncollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02211742 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.